Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis

Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis

The Facilitated Immunoglobulin Administration Registry And Outcomes (FIGARO) Study was a European, multicenter, prospective, observational study conducted across Europe designed to provide insights on the clinical use and tolerability of facilitated subcutaneous immunoglobulin (fSCIG). Data herein a...

Full description

Bibliographic Details
Main Authors: Maria Dimou, Matthaios Speletas, Cinzia Milito, Aleksandra Pyzik, Dörte Huscher, Marta Kamieniak, David Pittrow, Michael Borte
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cancers
Subjects:
facilitated subcutaneous immunoglobulin
immunoglobulin replacement therapy
secondary immunodeficiency diseases
real-world study
self-administration
Online Access:https://www.mdpi.com/2072-6694/15/18/4524

Internet

https://www.mdpi.com/2072-6694/15/18/4524

Similar Items